Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bicalutamide versus spironolactone for female pattern hair loss
RBR-7kp4x6pPhase 4Completed
- Sponsor
- Clinica Sanabria
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Female Pattern Hair Loss (FPHL) comparing Bicalutamide with Spironolactone (2 arms). Started Sep 2023; status: completed.
02
Drugs
bicalutamidespironolactone
03
Conditions
Female Pattern Hair Loss (FPHL)
Beyond the preview
Go deeper on RBR-7kp4x6p.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-7kp4x6p.